• Glenn Hearson

Post authorisation safety study of Esbriet (PASSPORT)

Completed IPF Study

Post authorisation Safety Study (PASS) of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long Term Safety in a Real World Setting.

Principle Investigator: Professor Gisli Jenkins



Copyright Nottingham Respiratory Research Unit 2016

  • Nottingham RRU/BRC Facebook
  • Nottingham BRC Lung/NRRU Twitter

Tel: 0115-8404844